Select Page

The Infinium Global Research analyzes the Consumer Healthcare Market over the period of 2019 to 2025. This report also provides detailed qualitative and quantitative analyses of the market dynamics, market size and future trends in global consumer healthcare market. It will help a lot of decision makers to develop strategies and find new opportunities in the global markets of consumer healthcare. The report covers market changing aspects including drivers, restraints, opportunities, and trends expected to encouragement the expansion of the consumer healthcare market during the period.

“We are Now Including the Impact Analysis of the COVID-19 on this Premium Report and the Forecast Period of this Report shall be Revised to 2020-2026.”  The Section on the Impact of COVID-19 on this Market is Included in the Report for Free. To Know More Request Sample of this Report:

The consumer healthcare market or industry is extremely fragmented and leading manufacturers remain to strengthen their position in the market through high-profile acquisition and various marketing strategy. Consumer healthcare deals with products in skin health, wellness, nutrition, and oral health. Consumer healthcare products mainly constitute OTC (over-the-counter) drugs which are medicines, without a prescription from a healthcare professional, which are sold directly to the consumer.

Consumer Healthcare Market: Competitive Landscape

The key players in the consumer healthcare market are Johnson & Johnson, Pfizer Inc., Boehringer Ingelheim GmbH, Abbott Laboratories, Sanofi, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Amway, BASF SE, and Bayer AG., and many others.

Consumer Healthcare Market is Driven by A Rise in Disposable Income and the Approval of Preventive & Wellness Medicine

The consumer healthcare market is driven by a rise in disposable income and the approval of preventive & wellness medicine. Moreover, increasing healthcare costs, large demand for self-medication, the growing geriatric population which is more susceptible to contracting diseases, shift from medication prescription to OTC products, and deterioration in mental health are also expected to drive the consumer healthcare market. However, the presence of counterfeit pharmaceuticals is and stringent regulations of government for the healthcare industry is anticipated to restrict the growth of the consumer healthcare market. Nonetheless, the growing demand for branded products, along with accelerated & development use of online sources, OTC generics, and private labels is estimated to create a new opportunity for the global consumer healthcare market.

Consumer Healthcare Market: Segmentation

The report on the global consumer healthcare market covers segments such as product, and distribution network. The disease type segment is further segmented into OTC pharmaceuticals and dietary supplements. On the basis of the distribution network, the consumer healthcare market is segmented into departmental stores, independent retailers, pharmacies or drugstores, specialist retailers, and supermarkets or hypermarkets.

North America Held the Largest Revenue Share for the Global Consumer Healthcare Market

On the basis of region, the global consumer healthcare market is bifurcated into North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa. North America held the largest revenue share for the global consumer healthcare market in 2018 owing Major consumer products, CRAMS organizations, pharmaceutical, health insurance companies, medical device, and manufacturing companies are located in the region followed by Europe. The ECHA (European Chemicals Agency) EC (European Commission’s) Chemical regulation body,  is mainly focused on evaluation and testing of chemicals and entities under REACH, to assess the effect on people of these substances and aims to update and fill the gaps in dossiers to enhance the data quality. Asia Pacific is expected to exhibit rapid growth owing to the cheap labor and lower cost of manufacturing, less regulatory complications, with a large number of GMP (Good manufacturing practice) facilities.

Browse Complete Report@

Reasons to Buy this Report:

  • Comprehensive analysis of global as well as regional markets of the consumer healthcare.
  • Complete coverage of all the product type and applications segments to analyze the trends, developments, and forecast of market size up to 2025.
  • Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.
  • Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.